Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImperial Innovations Group Regulatory News (IVO)

  • There is currently no data for IVO

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Nexeon completes manufacturing facility

24 Apr 2014 07:00

RNS Number : 3752F
Imperial Innovations Group plc
24 April 2014
 



24 April 2014

 

Imperial Innovations Group plc

 

Nexeon completes commissioning of manufacturing facility

Imperial Innovations plc (AIM: IVO, "Innovations", "the Group") is pleased to note that its portfolio company Nexeon Ltd, has completed the construction and commissioning of its process development and manufacturing facility at its headquarters in Oxfordshire.  

Nexeon, which is Innovations' second largest portfolio company by value, is developing silicon anode technology for the next generation of lithium ion (Li-ion) batteries. Silicon anodes offer benefits over conventional carbon anodes as they enable the development of lithium-ion cells with greater energy density. Nexeon has established a growing portfolio of patents covering materials and fabrication processes.

The company's new manufacturing plant is capable of producing over 20 tonnes of product a year, and has been built to handle a wide range of materials and reagents. In addition to the manufacturing capability, the new facility includes integrated laboratories for Process Development and Material Characterisation.

Russ Cummings, CEO of Imperial Innovations, said:

"Nexeon's new 20 tonne plant is highly versatile, with end-use applications spanning consumer electronic devices and electric vehicles. We look forward to the company sampling customers with products from this advanced manufacturing facility."

Enquiries:

 

Imperial Innovations Group Plc

020 3053 8834

Russ Cummings, Chief Executive Officer

Jon Davies, Director of Communications

 

Instinctif Partners

020 7457 2020

Adrian Duffield/Mel Toyne-Sewell

 

J.P. Morgan Cazenove

020 7742 4000

Michael Wentworth Stanley/Alec Pratt

 

Cenkos Securities

020 7397 8900

Andy Roberts/Christopher Golden

 

 

Notes to editors

 

About Imperial Innovations - www.imperialinnovations.co.uk 

 

Imperial Innovations creates, builds and invests in pioneering technologies developed from the academic research of the UK's four leading Universities. The Group supports scientists and entrepreneurs in the commercialisation of their ideas and intellectual property by leading the formation of new companies, providing facilities in the early stages, providing investment and encouraging co-investment to accelerate development, providing operational expertise and recruiting high-calibre management teams. It also runs an Incubator in London that is the initial home for many of its technology spin-outs.

Originally formed as the Technology Transfer office for Imperial College - a role it still carries out today, Innovations also invests in opportunities arising from intellectual property developed at, or associated with, Cambridge University, Oxford University and University College London. These are the top four research intensive universities in Europe with a research income of over £1.3 billion per annum.

Innovations invests in the most promising opportunities from whichever technology sector they arise, but has built particular expertise in the key sectors of: therapeutics, medtech, engineering and materials, and ICT.

Since listing in 2006, Innovations has invested a total of £160.9 million across its portfolio companies, which have raised collectively investment of over £750.0 million. Innovations' largest holding is in Circassia Pharmaceuticals, which listed on the London Stock Exchange main market in March 2014 with a market capitalisation of £581.0 million.

About Nexeon

Nexeon Ltd. ('Nexeon') is a battery materials company developing silicon anodes for the next generation of lithium-ion rechargeable batteries. A spin out of Imperial Innovations, Nexeon scientists have shown that producing silicon with particular morphologies makes it possible to overcome its limitations as an anode material. Batteries made with silicon anodes have significant performance advantages over their traditional equivalents.

Nexeon is based in Oxfordshire, and has a fully automated and instrumented pilot plant that closely represents a commercial manufacturing facility, and allows an accurate understanding of the processes and costs associated with making anode materials. The technology has been conceived with a 'drop in' approach, requiring the minimum of changes to an existing Li-ion battery manufacturing operation.

Nexeon has established a growing portfolio of patents covering materials and fabrication processes, and is building a store of available know-how which is available through licensing.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAEAXLDAASLEFF
Date   Source Headline
24th Jan 20117:00 amRNSResult of equity raise
6th Jan 20111:11 pmRNSResult of General Meeting
9th Dec 201011:10 amRNSDirectors' Dealings
8th Dec 20104:55 pmRNSPublication of Prospectus
7th Dec 20107:09 amRNS£140m equity raising
12th Oct 20107:00 amRNSFinal Results
15th Sep 20104:17 pmRNSNotice of Results
2nd Sep 20109:00 amRNSPortfolio News
25th Aug 20109:00 amRNSPortfolio Company News
20th Aug 20109:00 amRNSFurther portfolio investments
22nd Jun 201010:37 amRNSDirectors' Dealings
1st Jun 20107:01 amRNSSale of portfolio company
27th Apr 20107:00 amRNSInterim Results
23rd Apr 20109:05 amRNSMIT praises Novacem technology
9th Apr 20107:00 amRNSNotice of Results
6th Apr 20108:00 amRNSInvestment in portfolio company
11th Mar 20108:00 amRNSFurther Investment in portfolio company
8th Mar 20104:19 pmRNSChange of Adviser
5th Mar 201011:05 amRNSTR1 - Notification of major interest in shares
3rd Mar 20108:30 amRNSMilestone for Nexeon
2nd Mar 20107:16 amRNSMembrane Extraction Technology sold
1st Mar 20107:00 amRNSInvestment in portfolio company
17th Feb 20107:00 amRNSFurther Investment In PolyTherics
8th Feb 201012:41 pmRNSDirector Dealing
5th Feb 20103:42 pmRNSNotification of Major Interest in Shares
27th Jan 20107:00 amRNSLicence Agreement
19th Jan 20105:58 pmRNSDirector Dealings
19th Jan 201011:47 amRNSAdditional Listing of Shares
21st Dec 200911:32 amRNSBoard Appointment
15th Dec 200912:04 pmRNSResult of AGM
11th Dec 20097:00 amRNSFurther investment in portfolio company
8th Dec 200910:14 amRNSDirector Dealing's
27th Nov 200910:31 amRNSHolding(s) in Company
11th Nov 200911:42 amRNSNotice of AGM
21st Oct 20093:20 pmRNSDirector Dealings
20th Oct 20097:00 amRNSFurther Investment In Portfolio Company
13th Oct 20094:17 pmRNSDirector Dealing
12th Oct 20093:09 pmRNSDirectors' Dealings
8th Oct 20097:00 amRNSFurther Investment in Plaxica
7th Oct 20097:00 amRNSFinal Results
21st Sep 20097:00 amRNSInvestment in Portfolio Company
1st Sep 20097:00 amRNSLeads ?2 funding round in Molecular Vision
25th Aug 20093:30 pmRNSNotice of Results
10th Aug 20097:00 amRNSInvestments in portfolio companies
3rd Jul 20097:00 amRNSInvestment in OSspray
26th Jun 20097:00 amRNSDisposal of investment in InforSense
2nd Jun 20094:30 pmPRNHolding(s) in Company
28th May 20098:05 amRNSPortfolio Company IP Trade Sale to Technip
20th May 20097:00 amRNSDirector/PDMR Shareholding
27th Apr 20097:00 amPRNHalf-yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.